High-dose influenza vaccine shows no additional benefit for heart disease patients

NIH-funded study finds higher dose is not more effective at reducing serious flu complications in this high-risk group.

19h

NIH researchers link cases of ALS and FTD to a mutation associated with Huntington’s disease

Previously unknown genetic connection could be a target for gene therapy.

20h

New updates to federal guidelines revamp asthma management

Updates to six key areas of asthma care focus on improving diagnosis, management and treatment.

1d

NIH Statement on World AIDS Day 2020

We reflect both on the remarkable progress that has been made against HIV as well as the considerable challenges that remain.

3d

NIH announces restructured HIV clinical trials networks

Grant awards set stage for next seven years of science-driven HIV clinical research.

4d

Experimental Vaccine for Deadly Tickborne Virus Effective in Cynomolgus Macaques

Monkeys protected against CCHFV, which infects thousands of people annually.

4d

Fourth iteration of COVID-19 treatment trial underway

Study will enroll hospitalized adults with COVID-19 who require supplemental oxygen.

2w

Commonly used antibiotic shows promise for combating Zika infections

NIH preclinical study suggests FDA-approved tetracycline-based antibiotics may slow infection and reduce neurological problems.

2w

Decades of NIH research help lead to first FDA-approved treatment for progeria

NIH Director Francis S. Collins, M.D., Ph.D., available to discuss this major advance for rare, fatal pediatric disease.

2w

NIH expands research to improve COVID-19 testing among underserved and vulnerable populations

Research designed to rapidly implement testing strategies in populations disproportionately affected by COVID-19.

2w